Pembrolizumab (Keytruda, Merck) has received FDA approval as a first-line treatment in combination with axitinib (Inlyta) for patients with advanced renal cell carcinoma (RCC), making it the first indication for pembrolizumab in this patient population.
Precancerous cervical lesions, known as high-grade cervical lesions (CIN2+) can develop a few years after infection and have been used to monitor human papillomavirus (HPV) vaccine impact since cancers can take decades to develop.
What is causing KS's blood pressure to increase, despite maintaining a similar routine?
This approval marks the first generic naloxone nasal spray for use in a community setting by an individual without medical training.
Spring cleaning brings the opportunity to clean out unused and unwanted medicines that collect over time, just like old clothes from the closet or old food from the fridge.
This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.
Many health care professionals are being targeted by criminals, according to the DEA.
Failure to understand and appreciate the dynamics of the marketplace is costing pharmacy owners money.
Those who qualify and complete our survey are eligible to enter our drawing in which 1 lucky winner will receive a $250 American Express gift card.
The commercial availability of Bijuva offers an FDA approved alternative to marketed synthetic hormones or individual estrogen and progesterone products that have not been FDA-approved for combination use.
Antioxidants can be used to improve certain health conditions.
Alisha Barr, PharmD, asked her fellow pharmacist moms to donate supplies to her brother, who is deployed in Syria, and was overwhelmed by the response.
The study presented at the 29th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) in Amsterdam, Netherlands was a phase 2 randomized, active-controlled, double-blinded trial (N=444). All participants were ages 60 to 64 years.
Approved by the FDA on April 9, 2019, Amgen’s romosozumab-aqqg therapy (Evenity) is indicated for osteoporosis in postmenopausal women at high risk for fracture, defined as a history of osteoporotic fracture, or multiple risk factors for fracture; or patients who have failed or are intolerant to other available osteoporosis therapy.
The vaccine will use a cell-based candidate vaccine virus (CVV) for 4 influenza strains identified by the World Health Organization (WHO) for the upcoming flu season.
Estimates suggest that by 2020, 1.5 to 1.75 million people in the U.S. will be living with wet AMD, a leading cause of blindness worldwide and a rapidly growing public health concern, according to Novartis.
Officials with the US Food and Drug Administration have approved a therapy designed to provide weight management aid to overweight adults.
Changing patient habits, especially dietary habits, is a routine struggle for many people diagnosed with type 2 diabetes.
Why is this patient listing ciprofloxacin as an allergy?
If this new indication is approved, Invokana® would be the first diabetes medication to treat both T2D and CKD.
In this video, sponsored by Cardinal Health, female pharmacists and pharmacy owners discuss how collaboration can lead to success in the industry.
Kratom is a plant native to Southeast Asia which can produce stimulant and opioid-like effects.
Bladder cancers are associated with genetic mutations that are present in the patient's bladder or entire the lining of the lower urinary tract.
A study, which tested naturally occurring homoisoflavonoids found in the Hyacinthaceae plant family and their synthetic derivatives, focused on the abnormal growth of new blood vessel cells in the eye that are linked to types of blindness.
This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.
The expanded first-line indication makes pembrolizumab (Keytruda) monotherapy an option for more patients with non-small cell lung cancer.
The expansion of the Valyou Savings Program helps to address the challenge many patients face regarding unpredictable and unaffordable pricing for their insulin, according to the company.
The action requires the company to revise safety information that women and their health care professionals need when considering use of the drug.
The supplement (Equelle, Pharmavite) relies on S-equol, an intestinal bacterial metabolite of the soybean isoflavone daidzein that binds to select estrogen receptors in the body.
Across the United States, 5090 individuals were matched to approximately 2500 pharmacy residency programs.
